• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱小细胞癌与并存尿路上皮癌共同克隆起源的分子遗传学证据。

Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.

作者信息

Cheng Liang, Jones Timothy D, McCarthy Ryan P, Eble John N, Wang Mingsheng, MacLennan Gregory T, Lopez-Beltran Antonio, Yang Ximing J, Koch Michael O, Zhang Shaobo, Pan Chong-Xian, Baldridge Lee Ann

机构信息

Department of Pathology and Laboratory Medicine, Indiana University Medical Center, University Hospital 3465, 550 North University Boulevard, Indianapolis, Indiana 46202, USA.

出版信息

Am J Pathol. 2005 May;166(5):1533-9. doi: 10.1016/S0002-9440(10)62369-3.

DOI:10.1016/S0002-9440(10)62369-3
PMID:15855652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1606405/
Abstract

In most cases, small-cell carcinoma of the urinary bladder is admixed with other histological types of bladder carcinoma. To understand the pathogenetic relationship between the two tumor types, we analyzed histologically distinct tumor cell populations from the same patient for loss of heterozygosity (LOH) and X chromosome inactivation (in female patients). We examined five polymorphic microsatellite markers located on chromosome 3p25-26 (D3S3050), chromosome 9p21 (IFNA and D9S171), chromosome 9q32-33 (D9S177), and chromosome 17p13 (TP53) in 20 patients with small-cell carcinoma of the urinary bladder and concurrent urothelial carcinoma. DNA samples were prepared from formalin-fixed, paraffin-embedded tissue sections using laser-assisted microdissection. A nearly identical pattern of allelic loss was observed in the two tumor types in all cases, with an overall frequency of allelic loss of 90% (18 of 20 cases). Three patients showed different allelic loss patterns in the two tumor types at a single locus; however, the LOH patterns at the remaining loci were identical. Similarly, the same pattern of nonrandom X chromosome inactivation was present in both carcinoma components in the four cases analyzed. Concordant genetic alterations and X chromosome inactivation between small-cell carcinoma and coexisting urothelial carcinoma suggest that both tumor components originate from the same cells in the urothelium.

摘要

在大多数情况下,膀胱小细胞癌与其他组织学类型的膀胱癌混合存在。为了解这两种肿瘤类型之间的致病关系,我们分析了同一患者组织学上不同的肿瘤细胞群体的杂合性缺失(LOH)和X染色体失活(女性患者)情况。我们检测了位于3号染色体p25 - 26区域(D3S3050)、9号染色体p21区域(IFNA和D9S171)、9号染色体q32 - 33区域(D9S177)以及17号染色体p13区域(TP53)的五个多态性微卫星标记,共检测了20例膀胱小细胞癌合并尿路上皮癌患者。使用激光辅助显微切割从福尔马林固定、石蜡包埋的组织切片中制备DNA样本。在所有病例中,两种肿瘤类型均观察到几乎相同的等位基因缺失模式,等位基因缺失的总体频率为90%(20例中的18例)。三名患者在单个位点的两种肿瘤类型中表现出不同的等位基因缺失模式;然而,其余位点的LOH模式相同。同样,在分析的四例病例中,两种癌成分均存在相同的非随机X染色体失活模式。膀胱小细胞癌与共存的尿路上皮癌之间一致的基因改变和X染色体失活表明,两种肿瘤成分均起源于尿路上皮中的同一细胞。

相似文献

1
Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.膀胱小细胞癌与并存尿路上皮癌共同克隆起源的分子遗传学证据。
Am J Pathol. 2005 May;166(5):1533-9. doi: 10.1016/S0002-9440(10)62369-3.
2
Clonal origin of lymph node metastases in bladder carcinoma.膀胱癌淋巴结转移的克隆起源
Cancer. 2005 Nov 1;104(9):1901-10. doi: 10.1002/cncr.21466.
3
Molecular evidence supporting field effect in urothelial carcinogenesis.支持尿路上皮癌发生中场效应的分子证据。
Clin Cancer Res. 2005 Sep 15;11(18):6512-9. doi: 10.1158/1078-0432.CCR-05-0891.
4
Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.膀胱癌旁经激光捕获显微切割的基质中的分子遗传学改变
Cancer. 2003 Nov 1;98(9):1830-6. doi: 10.1002/cncr.11747.
5
Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.肾乳头状细胞癌患者多灶性乳头状肿瘤独立起源的分子遗传学证据。
Clin Cancer Res. 2005 Oct 15;11(20):7226-33. doi: 10.1158/1078-0432.CCR-04-2597.
6
Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.膀胱肉瘤样尿路上皮癌的组织发生:共同克隆起源与分化分歧的证据。
J Pathol. 2007 Mar;211(4):420-30. doi: 10.1002/path.2129.
7
Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.激光捕获显微切割分析显示,膀胱低恶性潜能乳头状尿路上皮肿瘤中常出现等位基因缺失。
Cancer. 2004 Jul 1;101(1):183-8. doi: 10.1002/cncr.20343.
8
Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.多灶性乳头状甲状腺癌相同克隆起源的分子证据。
Clin Cancer Res. 2006 Apr 15;12(8):2414-8. doi: 10.1158/1078-0432.CCR-05-2818.
9
Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.伴有肉瘤样转化的透明细胞肾细胞癌中的克隆分歧与基因异质性
Cancer. 2005 Sep 15;104(6):1195-203. doi: 10.1002/cncr.21288.
10
[Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].[人膀胱移行细胞癌17号染色体p13区域杂合性缺失的精细定位]
Zhonghua Yi Xue Za Zhi. 2002 Feb 10;82(3):161-3.

引用本文的文献

1
Molecular Characteristics, Heterogeneity, Plasticity, and Cell of Origin of Neuroendocrine Bladder Cancer.神经内分泌膀胱癌的分子特征、异质性、可塑性及起源细胞
Cancer Heterog Plast. 2025;2(1). doi: 10.47248/chp2502010005. Epub 2025 Mar 6.
2
Small cell carcinoma of the bladder: Review of pathogenesis, presentation, and management.膀胱小细胞癌:发病机制、临床表现及治疗综述
Bladder Cancer. 2025 Aug 18;11(3):23523735251370956. doi: 10.1177/23523735251370956. eCollection 2025 Jul-Sep.
3
Small cell carcinoma with rhabdomyosarcomatous differentiation of the urinary bladder: an integrated clinicopathological and molecular characterization of five cases.膀胱小细胞癌伴横纹肌肉瘤分化:5例病例的综合临床病理及分子特征分析
Virchows Arch. 2025 Jul 8. doi: 10.1007/s00428-025-04174-7.
4
Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma.膀胱小细胞癌中转录因子定义亚型的临床病理特征
BMC Cancer. 2025 Apr 24;25(1):766. doi: 10.1186/s12885-025-14157-1.
5
Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder.来自膀胱癌细胞的富含蛋白质二硫键异构酶的细胞外囊泡支持膀胱肿瘤的存活和恶性转化。
Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03380-6.
6
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development.晚期膀胱癌尿路上皮和非尿路上皮亚型组织学的治疗进展:从病因到当前发展
Biomedicines. 2025 Jan 1;13(1):86. doi: 10.3390/biomedicines13010086.
7
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer.在膀胱尿路上皮癌中,MTAP表达缺失与9p21纯合缺失、不良肿瘤表型及非炎症微环境密切相关。
J Pathol Clin Res. 2025 Jan;11(1):e70012. doi: 10.1002/2056-4538.70012.
8
PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers.PD-1 阻断联合顺铂为基础的化疗治疗小细胞/神经内分泌膀胱癌和前列腺癌患者。
Cell Rep Med. 2024 Nov 19;5(11):101824. doi: 10.1016/j.xcrm.2024.101824. Epub 2024 Nov 12.
9
[Clinicopathological Features and Outcomes of Perioperative Treatment for Small Cell Carcinoma of the Bladder].[膀胱小细胞癌围手术期治疗的临床病理特征及结果]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Sep 20;55(5):1078-1084. doi: 10.12182/20240960501.
10
Treatment and survival of non-metastatic small cell carcinoma of the bladder from multiple centers in China.中国多中心非转移性小细胞膀胱癌的治疗与生存。
Sci Rep. 2024 Oct 20;14(1):24652. doi: 10.1038/s41598-024-75512-z.

本文引用的文献

1
Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.前列腺叶状肿瘤上皮和间质成分不同克隆起源的分子遗传学证据。
Am J Pathol. 2004 Oct;165(4):1395-400. doi: 10.1016/S0002-9440(10)63397-4.
2
Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients.膀胱小细胞癌:64例患者的临床病理分析
Cancer. 2004 Sep 1;101(5):957-62. doi: 10.1002/cncr.20456.
3
Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.激光捕获显微切割分析显示,膀胱低恶性潜能乳头状尿路上皮肿瘤中常出现等位基因缺失。
Cancer. 2004 Jul 1;101(1):183-8. doi: 10.1002/cncr.20343.
4
Loss of 14-3-3sigma in prostate cancer and its precursors.前列腺癌及其癌前病变中14-3-3西格玛蛋白的缺失。
Clin Cancer Res. 2004 May 1;10(9):3064-8. doi: 10.1158/1078-0432.ccr-03-0652.
5
Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis.睾丸恶性混合性生殖细胞肿瘤成熟畸胎瘤及其他组织学成分中的相同等位基因缺失。
Am J Pathol. 2003 Dec;163(6):2477-84. doi: 10.1016/S0002-9440(10)63602-4.
6
High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.EphA2受体酪氨酸激酶在前列腺上皮内瘤变中的高表达。
Am J Pathol. 2003 Dec;163(6):2271-6. doi: 10.1016/S0002-9440(10)63584-5.
7
Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.膀胱癌旁经激光捕获显微切割的基质中的分子遗传学改变
Cancer. 2003 Nov 1;98(9):1830-6. doi: 10.1002/cncr.11747.
8
Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma.睾丸生殖细胞肿瘤化疗后转移性成熟畸胎瘤旁的基质与畸胎瘤源自相同的祖细胞。
Cancer Res. 2003 Sep 15;63(18):6063-8.
9
Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature.膀胱类癌肿瘤。2例免疫组织化学研究及文献复习
Arch Pathol Lab Med. 2003 Jan;127(1):e22-4. doi: 10.5858/2003-127-e22-CTOTU.
10
Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor.对人类膀胱癌进行精确的显微切割显示,同一肿瘤中存在不同的肿瘤亚克隆。
Cancer. 2002 Jan 1;94(1):104-10. doi: 10.1002/cncr.10151.